Mangalam Organics Approves Rs 600 Million NCD Issuance to Bolster Financial Flexibility

Unknown Apr 02, 2026 550 Views

Mangalam Organics Ltd, a leading manufacturer of pine-based chemicals and synthetic resins, has announced board approval for the issuance of Non-Convertible Debentures (NCDs) aggregating up to Rs 600 million. The decision, finalized during the company’s board meeting on August 18, 2025, reflects a strategic move to strengthen its capital structure and support future growth initiatives through private placement of secured, unlisted, unrated, senior NCDs.

This capital-raising initiative comes at a time when Mangalam Organics is actively expanding its product portfolio and retail footprint across domestic and international markets. The funds are expected to be deployed toward working capital optimization, infrastructure upgrades, and potential capacity expansion.

Key Takeaways from the Board Approval

Board approves issuance of NCDs worth up to Rs 600 million
Instruments to be secured, unlisted, unrated, and senior in nature
Issuance to be executed via private placement under Companies Act provisions
Capital infusion aimed at enhancing liquidity and operational agility

Strategic Objectives Behind the NCD Issuance

Mangalam Organics’ decision to tap the debt market underscores its intent to diversify funding sources while maintaining balance sheet discipline. The NCD route offers flexibility in structuring repayment schedules and interest obligations, making it a preferred instrument for mid-sized industrial players.

Strengthen liquidity buffer amid volatile input costs
Support ongoing expansion in camphor and resin segments
Enhance financial readiness for export market growth
Avoid equity dilution while accessing long-term capital

Company Profile and Market Position

Mangalam Organics Ltd, headquartered in Mumbai, is a government-recognized export house with a strong presence in Europe, the US, Africa, and the Middle East. The company specializes in terpene chemistry, producing camphor, camphene, isobornyl acetate, and a range of synthetic resins. Its consumer brands Mangalam and CamPure have gained traction in the B2C segment, offering camphor-based products for religious and homecare use.

Manufacturing facility located in Kumbhivali, Maharashtra
Over five decades of experience in pine chemicals industry
Retail brands expanding through e-commerce and modern trade channels
Strong institutional customer base across pharma, fragrance, and adhesives sectors

Financial Snapshot and Recent Performance

While Mangalam Organics has maintained steady revenue growth, recent quarters have seen margin pressures due to raw material volatility and currency fluctuations. The NCD issuance is expected to provide a cushion against these challenges and enable smoother cash flow management.

FY25 Q1 net sales reported at Rs 129.70 crore
Export volumes showing consistent year-on-year growth
Focus on cost optimization and supply chain resilience

Regulatory and Compliance Framework

The NCD issuance will be governed by the Companies Act, 2013 and SEBI’s Listing Obligations and Disclosure Requirements. As the instruments are unlisted and unrated, Mangalam Organics will rely on private placement norms to attract institutional investors, including NBFCs, mutual funds, and family offices.

Instruments to be senior secured, ensuring priority in repayment
Tenure and coupon details to be finalized in subsequent disclosures
Compliance with RBI and SEBI norms for debt issuance

Outlook and Investor Sentiment

The move signals Mangalam Organics’ proactive approach to capital management and its readiness to scale operations in response to rising demand across industrial and consumer segments. Investors may view the NCD issuance as a sign of financial prudence, especially given the company’s conservative leverage profile and export-driven growth strategy.